Ambee Pharma recommends 26pc div

The board of directors of Ambee Pharmaceuticals Limited has recommended 26.0 per cent cash dividend for the 18 months period from January 01, 2015 to June 30, 2016.

The final approval will come during the Annual General Meeting (AGM) scheduled to be held on December 29 at 10:00am Tejgaon Industrial Area in Dhaka.

The record date for entitlement of dividend is on December 14.

The company has also reported earnings per share (EPS) of Tk 3.41 and net operating cash flow per share (NOCFPS) of Tk 12.06 for the 18 months period from January 01, 2015 to June 30, 2016.

The company has also reported earnings EPS of Tk 2.71 and NOCFPS of Tk 11.59 for the 12 months period from January 01, 2015 to December 31, 2015.

The company reported the earnings whereas Tk 0.70, and Tk 0.47 respectively for the 6 months period from January 01, 2016 to June 30, 2016.

Net asset value (NAV) per share of Tk 24.82 as of June 30, 2016 while Tk 24.12 as of December 31, 2015.

There will be no price limit on the trading of the shares of the company today (Wednesday) following its corporate declaration.

Each share of the pharma company, which was listed on the Dhaka bourse in 1986, closed at Tk 435.60 on Tuesday.

The company’s paid-up capital is Tk 25 million and authorised capital is Tk 24 million, while total number of securities is 2,400,000, according to statistics from the DSE.

The sponsor-directors own 75.26 per cent stake in the company, while institutional investors 5.46 per cent, and the general public19.28 per cent as on October 31, 2016.